COMMUNIQUÉS West-GlobeNewswire

Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development
24/09/2026
FDA clearance expands development of forazapadin into a second degenerative muscle disease with significant unmet medical need FSHD Canada Foundation to provide up to US$5 million in non-dilutive financing toward the [...]
Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics
24/09/2026
Collaboration leverages Atavistik Bio’s proprietary AMPS TM platform to identify and advance novel allosteric small molecules against multiple targets for cardiometabolic diseases Atavistik Bio to receive $70 million [...]
What CX Leaders Should Understand About Customer Support Outsourcing
24/09/2026
Transcom supports more than 300 clients globally, including disruptive e-commerce players and category-redefining fintechs, across 29 countries. Transcom's autopilot conversational AI bots resolve high-volume contacts [...]
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
24/09/2026
TORONTO and HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting [...]
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
24/09/2026
Dr. Nora Dimon, VP of Clinical Development, to present preclinical findings on the Company’s lead retinal program, CoTx-101, including non-human primate data Rodolphe Clerval, CEO, to deliver a corporate presentation at [...]
Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library
24/09/2026
ANN ARBOR, Mich., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a major [...]
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
24/09/2026
BERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensor technologies today announced that the Company has received a positive decision [...]
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
24/09/2026
Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel ARLINGTON, Mass., Sept. 24, 2026 ( [...]
Immuneering to Present at the ESMO Congress 2026
24/09/2026
- Trial in progress poster will highlight the ongoing Phase 3 MAPKeeper 301 trial of atebimetinib + mGnP in first-line pancreatic cancer patients - NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation ( [...]
Sofwave Receives NMPA Approval in Mainland China
24/09/2026
NMPA approval supported by a 200-subject, randomized, controlled study in China demonstrating statistically significant improvement in mid-to-lower facial wrinkles and a favorable safety profile China represents a [...]
Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress
24/09/2026
Final Phase 2a data from the BIRCH trial of BIOX-101 in acute intracerebral hemorrhage, selected for a Late-Breaking Science oral presentation New data show statistically significant improvements across multiple [...]
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
24/09/2026
Heidelberg site to lead GMP development of lactoperoxidase and glucose oxidase for Phase II clinical trials HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Belgian biopharmaceutical company Flen Health has [...]
Reminder: Register Now | Unlocking the Growth - BioPorto Investor Meeting, October 7
24/09/2026
September 24, 2026 News release Reminder: Register Now | Unlocking the Growth - BioPorto Investor Meeting, October 7 As BioPorto continues to advance its commercial strategy and capitalize on emerging clinical [...]
BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa
24/09/2026
BOOST Pharma (“BOOST” or “the Company”), a clinical‑stage biopharmaceutical company developing novel, first‑in‑class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced that [...]
Ona Therapeutics advances as a clinical-stage company and appoints Aleix Prat, MD, PhD, as Chief Medical Officer
24/09/2026
More than half of the patients planned for the clinical study have already been enrolled, with the trial progressing rapidly through dose escalation Advancement of ONA-255 marks an important milestone following Ona's $ [...]
Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders
24/09/2026
Differentiated approach directly and selectively enhances TrkB activity, a central regulator of neuroplasticity New funds will advance lead programme KTX-0141 through IND/CTA-enabling studies and Phase 1/1b clinical [...]
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines
24/09/2026
BEIJING, Sept. 24, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Company [...]
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development
24/09/2026
OXFORD, United Kingdom and BURLINGTON, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP) (“ Scancell ”, or the “ Company ”), a late-stage clinical immuno-oncology company developing active [...]
La transformation stratégique soutient la performance de Roquette au premier semestre 2026
24/09/2026
La transformation stratégique soutient la performance de Roquette au premier semestre 2026 Croissance du chiffre d'affaires de +9 % à 2 586 M€ et progression de l'EBITDA Courant de +18 % à 337 M€. La performance a été [...]

Pages